BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 17524958)

  • 1. Randomized clinical trials with a pre- and a post-treatment measurement: repeated measures versus ANCOVA models.
    Winkens B; van Breukelen GJ; Schouten HJ; Berger MP
    Contemp Clin Trials; 2007 Nov; 28(6):713-9. PubMed ID: 17524958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parametric versus non-parametric statistics in the analysis of randomized trials with non-normally distributed data.
    Vickers AJ
    BMC Med Res Methodol; 2005 Nov; 5():35. PubMed ID: 16269081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal number of repeated measures and group sizes in clinical trials with linearly divergent treatment effects.
    Winkens B; Schouten HJ; van Breukelen GJ; Berger MP
    Contemp Clin Trials; 2006 Feb; 27(1):57-69. PubMed ID: 16260188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of covariance with pre-treatment measurements in randomized trials: comparison of equal and unequal slopes.
    Funatogawa I; Funatogawa T
    Biom J; 2011 Sep; 53(5):810-21. PubMed ID: 21887795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Change from baseline and analysis of covariance revisited.
    Senn S
    Stat Med; 2006 Dec; 25(24):4334-44. PubMed ID: 16921578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Should baseline be a covariate or dependent variable in analyses of change from baseline in clinical trials?
    Liu GF; Lu K; Mogg R; Mallick M; Mehrotra DV
    Stat Med; 2009 Sep; 28(20):2509-30. PubMed ID: 19610129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A simple sample size formula for analysis of covariance in randomized clinical trials.
    Borm GF; Fransen J; Lemmens WA
    J Clin Epidemiol; 2007 Dec; 60(12):1234-8. PubMed ID: 17998077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of covariance in parallel-group clinical trials with pretreatment baselines.
    Crager MR
    Biometrics; 1987 Dec; 43(4):895-901. PubMed ID: 3427174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statistical issues on the analysis of change in follow-up studies in dental research.
    Blance A; Tu YK; Baelum V; Gilthorpe MS
    Community Dent Oral Epidemiol; 2007 Dec; 35(6):412-20. PubMed ID: 18039282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analyzing pre-post randomized studies with one post-randomization score using repeated measures and ANCOVA models.
    Wan F
    Stat Methods Med Res; 2019; 28(10-11):2952-2974. PubMed ID: 30084297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal time-points in clinical trials with linearly divergent treatment effects.
    Winkens B; Schouten HJ; van Breukelen GJ; Berger MP
    Stat Med; 2005 Dec; 24(24):3743-56. PubMed ID: 16320272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjustment for baseline measurement error in randomized controlled trials induces bias.
    Chan SF; Macaskill P; Irwig L; Walter SD
    Control Clin Trials; 2004 Aug; 25(4):408-16. PubMed ID: 15296815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A methodology for analysing a repeated measures and survival outcome simultaneously.
    Rochon J; Gillespie BW
    Stat Med; 2001 Apr; 20(8):1173-84. PubMed ID: 11304734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal designs for clinical trials with second-order polynomial treatment effects.
    Winkens B; Schouten HJ; van Breukelen GJ; Berger MP
    Stat Methods Med Res; 2007 Dec; 16(6):523-37. PubMed ID: 17698939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A note on variance estimation in random effects meta-regression.
    Sidik K; Jonkman JN
    J Biopharm Stat; 2005; 15(5):823-38. PubMed ID: 16078388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variance identification and efficiency analysis in randomized experiments under the matched-pair design.
    Imai K
    Stat Med; 2008 Oct; 27(24):4857-73. PubMed ID: 18618425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analyzing bivariate repeated measures for discrete and continuous outcome variables.
    Rochon J
    Biometrics; 1996 Jun; 52(2):740-50. PubMed ID: 8672710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statistical methods for active extension trials.
    Hu Z; Follmann D
    Stat Med; 2007 May; 26(12):2433-48. PubMed ID: 17066400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of covariance with pre-treatment measurements in randomized trials under the cases that covariances and post-treatment variances differ between groups.
    Funatogawa T; Funatogawa I; Shyr Y
    Biom J; 2011 May; 53(3):512-24. PubMed ID: 22223254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.